SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-051364
Filing Date
2023-06-23
Accepted
2023-06-23 16:15:30
Documents
7
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea180805-6k_canfitebio.htm 6-K 13513
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL GENERAL MEETING ea180805ex99-1_canfitebio.htm EX-99.1 95605
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL G ea180805ex99-2_canfitebio.htm EX-99.2 28362
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHAREHOLDERS WITH RESPECT TO THE ea180805ex99-3_canfitebio.htm EX-99.3 1444
5 GRAPHIC ex99-1_001.jpg GRAPHIC 4452
6 GRAPHIC ex99-3_001.jpg GRAPHIC 340876
7 GRAPHIC ex99-3_002.jpg GRAPHIC 250486
  Complete submission text file 0001213900-23-051364.txt   960235
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 231037847
SIC: 2834 Pharmaceutical Preparations